Halozyme Therapeutics, Inc. is a biopharmaceutical company that produces treatments for diabetes, cancer, and skin diseases. The company focuses on developing new drug delivery methods. Its technology platform is based on recombinant human hyaluronidase and additional enzymes.
Get AI Stock Predictions Now
Download our app for real-time AI-powered stock predictions on iOS, Android, Windows and macOS
Disclaimer: AI-generated stock predictions are for informational purposes only and do not constitute financial advice. Past performance does not guarantee future results. Always do your own research and consult a qualified financial advisor before making investment decisions. Investing involves risk, including possible loss of principal.